Peripheral Intravascular Lithotripsy Global Market Report 2026

The peripheral intravascular lithotripsy market size has grown rapidly in recent years. It will grow from $1.29 billion in 2025 to $1.46 billion in 2026 at a compound annual growth rate (CAGR) of 12.9%. The growth in the historic period can be attributed to rising prevalence of peripheral artery disease, adoption of traditional angioplasty techniques, increasing geriatric population, demand for safer vascular interventions, growth of hospital cardiovascular departments.

The peripheral intravascular lithotripsy market size is expected to see rapid growth in the next few years. It will grow to $2.39 billion in 2030 at a compound annual growth rate (CAGR) of 13.1%. The growth in the forecast period can be attributed to adoption of intravascular lithotripsy devices, integration with advanced imaging modalities, demand for precision vascular therapies, expansion of ambulatory surgical centers, investment in next-generation IVL catheters. Major trends in the forecast period include minimally invasive treatment adoption, advanced catheter technologies, integration with imaging systems, personalized pad management, real-time procedure monitoring.

The rising prevalence of cardiovascular diseases is anticipated to drive the growth of the peripheral intravascular lithotripsy market in the coming years. Cardiovascular diseases encompass conditions affecting the heart and blood vessels, such as coronary heart disease, stroke, heart failure, and arrhythmias. The prevalence of these diseases is increasing due to aging populations, as older age substantially raises the likelihood of developing heart and vascular conditions, particularly among individuals over 65 years. Peripheral intravascular lithotripsy addresses cardiovascular diseases by safely breaking down calcified arterial plaques, enhancing vessel compliance, and improving blood flow to reduce the risk of ischemic complications. For example, in February 2025, according to the Joint Strategic Needs Assessment, a UK-based community health center, deaths from cardiovascular disease in Blackpool rose from 178 in 2022 to 185 in 2023. Consequently, the growing prevalence of cardiovascular diseases is fueling the expansion of the peripheral intravascular lithotripsy market.

Key companies operating in the peripheral intravascular lithotripsy market are focusing on developing advanced products, such as larger-diameter catheters, to treat complex calcification in larger peripheral vessels and improve patient outcomes. Larger-diameter IVL catheters refer to advanced devices designed to deliver sonic pressure waves to modify calcified plaque in arteries like the iliac and common femoral, which are otherwise difficult to treat with standard techniques. For example, in March 2025, Shockwave Medical Inc., a US-based medical device company, launched the Shockwave Javelin Peripheral IVL Catheter following clearance by the U.S. Food and Drug Administration (FDA). It is an innovative forward IVL platform designed to modify calcium and cross extremely narrowed vessels that are challenging for conventional devices to treat. The Javelin catheter features a 150 cm working length and a single distal emitter capable of generating up to 120 shockwave pulses that create a spherical energy field extending beyond the catheter tip, delivering lithotripsy closer to the calcium compared with balloon-based IVL systems. It enhances the ability of clinicians to treat subtotal occlusions and complex calcified lesions across the peripheral anatomy, potentially improving procedural success and patient outcomes.

In April 2024, Johnson & Johnson, a US-based healthcare company, completed the acquisition of Shockwave Medical Inc. for $13.1 billion. Through this acquisition, Johnson & Johnson seeks to expand and reinforce its presence in the rapidly growing cardiovascular intervention market by incorporating Shockwave’s innovative intravascular lithotripsy (IVL) technology into its MedTech portfolio. Shockwave Medical Inc. is a US-based company that offers peripheral intravascular lithotripsy (IVL) systems for the treatment of severely calcified peripheral arterial disease both above and below the knee.

Major companies operating in the peripheral intravascular lithotripsy market are Johnson & Johnson, Boston Scientific Corporation, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., Lepu Medical Technology Co Ltd., Biosensors International Group Ltd., Amplitude Vascular Systems Inc., AVS Pulse Inc., Genesis MedTech Pte Ltd, Jiangsu Pupeng Medical Technology Co Ltd., Elixir Medical Corporation, Spectrumedics International, FastWave Medical Inc., Cardiovascular Systems Inc., Suzhou Zhonghui Medical Technology Co Ltd.

North America was the largest region in the peripheral intravascular lithotripsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral intravascular lithotripsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the peripheral intravascular lithotripsy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The peripheral intravascular lithotripsy market consists of revenues earned by entities by providing services such as shockwave therapy procedures, catheter-based device deployment, clinical consultation and patient assessment, post-procedural monitoring and follow-up care, and training and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The peripheral intravascular lithotripsy market also includes sales of portable generator systems, connector cables and interface accessories, sterile procedure packs, and imaging and navigation support devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Peripheral intravascular lithotripsy is a minimally invasive procedure used to treat calcified plaque in peripheral arteries, particularly in the legs. It employs sonic pressure waves delivered via a specialized balloon catheter to fracture hardened calcium within the artery walls, enhancing blood flow and allowing safer, more effective balloon angioplasty or stent placement.

The key device components of peripheral intravascular lithotripsy include intravascular lithotripsy (IVL) catheters, generator or console systems, and accessories or connectors. IVL catheters are specialized devices that deliver acoustic pressure waves to calcified vascular lesions, enabling safe plaque modification and vessel expansion. They are used for indications including peripheral artery disease (PAD), dialysis access lesions, coronary applications, and others. Applications include femoral-popliteal, iliac artery, and infrapopliteal procedures, serving hospitals, ambulatory surgical centers, and specialty vascular clinics.

Tariffs have influenced the peripheral intravascular lithotripsy market by increasing costs of importing catheters, generator systems, and accessories. This impact is particularly pronounced in regions such as North America and Europe that rely heavily on imports for advanced devices. As a result, hospitals and specialty vascular clinics face higher procurement costs, prompting local manufacturing and innovation in cost-effective IVL solutions. Despite challenges, tariffs encourage domestic production and supply chain diversification, supporting long-term market stability.

The peripheral intravascular lithotripsy market research report is one of a series of new reports that provides peripheral intravascular lithotripsy market statistics, including peripheral intravascular lithotripsy industry global market size, regional shares, competitors with a peripheral intravascular lithotripsy market share, detailed peripheral intravascular lithotripsy market segments, market trends and opportunities, and any further data you may need to thrive in the peripheral intravascular lithotripsy industry. This peripheral intravascular lithotripsy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.